Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 IL17F [1] Th17 cell differentiation D11550 Bimekizumab [3] 46, 97, 271
2 MAPK14 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
3 MAPK14 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
4 MTOR [4] Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D00753 Sirolimus [41] 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331
5 MTOR [4] Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D02714 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277
6 MTOR [4] Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D06068 Temsirolimus [4] 13, 34, 89, 331
7 HLA-DMA [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
8 HLA-DMB [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
9 HLA-DOA [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
10 HLA-DOB [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
11 HLA-DPA1 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
12 HLA-DPB1 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
13 HLA-DQA1 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
14 HLA-DQA2 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
15 HLA-DQB1 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
16 HLA-DRA [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
17 HLA-DRB1 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
18 HLA-DRB3 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
19 HLA-DRB4 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
20 HLA-DRB5 [5] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
21 IFNG [4] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D04242 Fontolizumab [1] 46
22 IFNG [4] Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D11120 Emapalumab [2] 49, 107
23 IFNGR1 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326
24 IFNGR2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326
25 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
26 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D06635 Rilonacept [4] 51, 106, 107, 266
27 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09315 Canakinumab [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
28 IL1B [6] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09911 Gevokizumab [4] 41, 50, 56, 269
29 IL1R1 [1] Th17 cell differentiation D02934 Anakinra [19] 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299
30 IL2RA [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin [6] 2, 35, 49, 65, 96, 97
31 IL2RA [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03058 Basiliximab [6] 2, 50, 66, 97, 222, 228
32 IL2RA [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03639 Daclizumab [8] 13, 56, 60, 65, 97, 107, 283, 284
33 IL2RB [3] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation, Transcriptional misregulation in cancer D00748 Aldesleukin [6] 2, 35, 49, 65, 96, 97
34 IL2RG [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin [6] 2, 35, 49, 65, 96, 97
35 IL4 [1] Th17 cell differentiation D03117 Binetrakin [1] 46
36 IL4R [1] Th17 cell differentiation D10354 Dupilumab [4] 51, 98, 160, 162
37 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
38 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D08976 Pomalidomide [6] 28, 34, 51, 85, 227, 331
39 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D09669 Siltuximab [2] 28, 331
40 IL6 [7] Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D10080 Sirukumab [2] 41, 46
41 IL6R [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D02596 Tocilizumab [21] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
42 IL6R [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D10161 Sarilumab [5] 41, 46, 84, 107, 271
43 IL6R [2] Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D11079 Satralizumab [2] 11, 13
44 IL17A [1] Th17 cell differentiation D09967 Secukinumab [8] 13, 37, 41, 46, 107, 160, 269, 271
45 IL17A [1] Th17 cell differentiation D10071 Ixekizumab [6] 36, 37, 107, 162, 269, 271
46 IL17A [1] Th17 cell differentiation D11127 Tibulizumab [1] 53
47 IL17A [1] Th17 cell differentiation D11550 Bimekizumab [3] 46, 97, 271
48 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib [1] 228
49 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
50 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10308 Baricitinib [13] 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
51 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10653 Peficitinib [1] 46
52 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10871 Filgotinib [6] 46, 53, 96, 97, 222, 271
53 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10944 Itacitinib [5] 46, 51, 60, 97, 228
54 JAK1 [4] Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10994 Upadacitinib [8] 40, 41, 46, 49, 96, 97, 107, 271
55 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09959 Ruxolitinib [1] 228
56 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
57 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10308 Baricitinib [13] 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
58 JAK2 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10653 Peficitinib [1] 46
59 JAK3 [2] Th17 cell differentiation, Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
60 JAK3 [2] Th17 cell differentiation, Viral carcinogenesis D10653 Peficitinib [1] 46
61 LCK [2] Th17 cell differentiation, Yersinia infection D03658 Dasatinib [2] 51, 85
62 LCK [2] Th17 cell differentiation, Yersinia infection D06414 Dasatinib [2] 51, 85
63 NFKB1 [8] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D01146 Iguratimod [4] 46, 51, 53, 271
64 IL22 [1] Th17 cell differentiation D11953 Efmarodocokin alfa [2] 96, 97
65 IL23A [2] Th17 cell differentiation, Tuberculosis D09214 Ustekinumab [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
66 IL23A [2] Th17 cell differentiation, Tuberculosis D10400 Tildrakizumab [2] 162, 271
67 IL23A [2] Th17 cell differentiation, Tuberculosis D10438 Guselkumab [5] 37, 41, 51, 96, 97
68 IL23A [2] Th17 cell differentiation, Tuberculosis D10912 Brazikumab [2] 96, 97
69 IL23A [2] Th17 cell differentiation, Tuberculosis D11052 Risankizumab [4] 37, 96, 97, 271
70 IL23A [2] Th17 cell differentiation, Tuberculosis D11123 Mirikizumab [3] 37, 96, 97
71 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
72 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
73 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
74 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
75 PPP3CA [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [1] 222
76 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
77 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
78 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
79 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
80 PPP3CB [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [1] 222
81 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
82 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
83 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
84 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
85 PPP3CC [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [1] 222
86 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
87 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
88 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
89 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
90 PPP3R1 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [1] 222
91 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
92 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine [44] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
93 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus [1] 160
94 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus [34] 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
95 PPP3R2 [4] Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin [1] 222
96 PRKCQ [2] Vascular smooth muscle contraction, Th17 cell differentiation D09671 Sotrastaurin [1] 97
97 MAPK11 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
98 MAPK11 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
99 MAPK13 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
100 MAPK13 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
101 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D00094 Tretinoin [6] 2, 62, 63, 75, 94, 231
102 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D00348 Isotretinoin [4] 36, 39, 159, 160
103 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D01418 Tamibarotene [2] 26, 96
104 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D02754 Acitretin [1] 37
105 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D02815 Alitretinoin [1] 49
106 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D04162 Fenretinide [1] 299
107 RARA [2] Th17 cell differentiation, Transcriptional misregulation in cancer D06543 Vitamin A [3] 13, 53, 90
108 RELA [8] Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D12181 Edasalonexent [1] 113
109 RXRA [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
110 RXRA [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
111 RXRA [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
112 RXRB [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
113 RXRB [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
114 RXRB [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
115 RXRG [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin [1] 37
116 RXRG [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin [1] 49
117 RXRG [4] Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene [2] 13, 75
118 MAPK12 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
119 MAPK12 [8] VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
120 TGFB1 [3] Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09620 Fresolimumab [4] 51, 85, 222, 274
121 TYK2 [2] Th17 cell differentiation, Toxoplasmosis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
122 TYK2 [2] Th17 cell differentiation, Toxoplasmosis D11817 Deucravacitinib [2] 96, 97
123 CD3D [1] Th17 cell differentiation D05092 Muromonab [3] 60, 96, 97
124 CD3D [1] Th17 cell differentiation D06314 Visilizumab [2] 96, 97
125 CD3D [1] Th17 cell differentiation D08959 Otelixizumab [1] 46
126 CD3E [1] Th17 cell differentiation D05092 Muromonab [3] 60, 96, 97
127 CD3E [1] Th17 cell differentiation D06314 Visilizumab [2] 96, 97
128 CD3E [1] Th17 cell differentiation D08959 Otelixizumab [1] 46
129 CD3E [1] Th17 cell differentiation D11463 Mosunetuzumab [1] 49
130 CD3G [1] Th17 cell differentiation D05092 Muromonab [3] 60, 96, 97
131 CD3G [1] Th17 cell differentiation D06314 Visilizumab [2] 96, 97
132 CD3G [1] Th17 cell differentiation D08959 Otelixizumab [1] 46